Optimising prostate mpMRI: prepare for success

Clin Radiol. 2019 Nov;74(11):831-840. doi: 10.1016/j.crad.2018.12.003. Epub 2019 Jan 2.

Abstract

Multiparametric magnetic resonance imaging (MRI) now plays an essential role in prostate cancer diagnosis and management. The increasing use of MRI before biopsy makes obtaining images of the highest quality vital. The European Society of Urogenital Radiology (ESUR) 2012 guidelines and subsequent Prostate Imaging -Reporting Data System (PI-RADS) version 2 recommendations in 2015 address the technical considerations for optimising MRI acquisition; however, the quality of the multiparametric sequences employed depends not only on the hardware and software utilised and scanning parameters selected, but also on patient-related factors, for which current guidance is lacking. Patient preparation factors include bowel peristalsis, rectal distension, the presence of total hip replacement (THR), post-biopsy haemorrhage, and abstinence from ejaculation. New evidence has been accrued since the release of PI-RADS v2, and this review aims to explore the key issues of patient preparation and their potential to further optimise the image quality of mpMRI.

Publication types

  • Review

MeSH terms

  • Artifacts
  • Contraindications, Procedure
  • Ejaculation / physiology
  • Gastrointestinal Agents / administration & dosage
  • Humans
  • Image-Guided Biopsy / methods
  • Male
  • Multiparametric Magnetic Resonance Imaging / adverse effects
  • Multiparametric Magnetic Resonance Imaging / methods*
  • Multiparametric Magnetic Resonance Imaging / standards
  • Neoplasm Staging
  • Organ Size
  • Parasympatholytics / administration & dosage
  • Patient Care Planning
  • Peristalsis / drug effects
  • Prostatic Neoplasms / diagnosis*
  • Prostheses and Implants / adverse effects
  • Quality of Health Care
  • Seminal Vesicles / anatomy & histology
  • Sensitivity and Specificity
  • Time Factors

Substances

  • Gastrointestinal Agents
  • Parasympatholytics